Lower, more frequent doses of nanomedicines may enhance cancer treatment: The strategy may make tumors more vulnerable to anti-cancer therapies

Both nanomedicines and metronomic scheduling -- when medications are given at lower, more frequent doses -- can correct abnormalities surrounding tumors that help protect cancer cells and foster their growth and spread. Combining nanomedicines and metronomic scheduling may help improve cancer treatment strategies.